Skip to main content
Clinical Trials/NCT02658903
NCT02658903
Unknown
Phase 1

Prevention of Catheter Associated Lower Urinary Infections Using the Oxys Indwelling Catheter

Oxys Medical AG1 site in 1 country54 target enrollmentJanuary 2016

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Urinary Infections
Sponsor
Oxys Medical AG
Enrollment
54
Locations
1
Primary Endpoint
Bacterial biofilm on catheter, assessed by ultrasonic culture of catheter tip removed at the end of the study.
Last Updated
10 years ago

Overview

Brief Summary

The safety and efficacy of a urinary catheter designed to prevent catheter associated urinary infections is studied.

Detailed Description

This study is an open randomized controlled trial of 4 weeks duration. The intervention is a novel urinary catheter with an electromagnetic therapy to prevent catheter associated infections. The catheter is used in patients which require longterm urinary catheterization over at least 1 month. The endpoint is bacteriological exam and the laboratory is blinded to the therapy status. Weekly urinary cultures are drawn and a sonication culture of the catheter tip is performed to detect and characterize the biofilm. A colonization rate of \>95% is anticipated in the control arm. Therefore a 50% reduction in colonization can be detected with 54 patients, a 90% reduction in colonization can be detected with 20 patients with a power of 0.9.

Registry
clinicaltrials.gov
Start Date
January 2016
End Date
January 2017
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Oxys Medical AG
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient with need for an indwelling urinary catheter to be placed at least for 4 weeks, which are willing and capable to provide informed consent. Most patients have spinal cord injury and are treated by the prinicpal investigator.

Exclusion Criteria

  • Need for antibiotic treatment for any infections
  • Urological intervention or need for catheter change within study duration of 4 weeks

Outcomes

Primary Outcomes

Bacterial biofilm on catheter, assessed by ultrasonic culture of catheter tip removed at the end of the study.

Time Frame: 4 weeks

Secondary Outcomes

  • Significant bacteriuria assessed by weekly bacterial cultures.(every week during 4 weeks)
  • occurence of adverse events(within 4 weeks)
  • Clinically symptomatic catheter associated lower urinary infections.(4 weeks)

Study Sites (1)

Loading locations...

Similar Trials